Nivolumab in the CheckMate 374, CheckMate 016, and CheckMate 025 Trials

[Anonymous]

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018; 16 (1): 20

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索